Hypertension quiz results

Referrals and patient selection

1. According to the World Health Organization, approximately how many adults (ages 30–79) worldwide have hypertension?

The number 1.28 represents the 1.28 billion people estimated to have hypertension worldwide.

An estimated 1.28 billion adults ages 30–79 years worldwide have hypertension, according to the WHO. Most (two-thirds) live in low- and middle-income countries.1

2. What percentage of adults with hypertension worldwide have their condition under control?

The number 21 represents the number of adults with hypertension worldwide who have their condition under control.

Approximately 1 in 5 adults, or 21%, with hypertension have it under control, according to the WHO.1

3. Reducing office systolic blood pressure by 10 mmHg reduces the risk of heart failure by how much?

The number 28 represents the potential reduction in the risk of heart failure from a 10 mmHg reduction in blood pressure.

According to a meta-analysis of more than 600,000 participants in 123 studies, a 10 mmHg reduction in blood pressure reduces the risk of heart failure by 28%.2

Explore patient selection resources.

Find the right patients

Explore resources for identifying patients who could benefit from the Symplicity™ blood pressure procedure.

Explore data from multiple randomized controlled trials of Medtronic RDN.

Multiple randomized controlled trials

See how the Symplicity blood pressure procedure has demonstrated significant and safe blood pressure reductions.1–3

Get patient materials to educate patients about Medtronic RDN.

Answer patient questions

Use these patient-friendly resources to educate patients about the Symplicity blood pressure procedure.

See practice resources to educate your patients about hypertension and Medtronic Renal Denervation.

Strengthen your practice

Find resources designed to help you support your patients with hypertension.

1

Hypertension Key Facts. World Health Organization. Published August 25, 2021. Accessed December 10, 2021.

2

Ettehad D, Emdin CA, Kiran A, et al. Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis. The Lancet. 2016;387:957-67.

3

Böhm M, Kario K, Kandzari DE, et al. Efficacy of catheter-based renal denervation in the absence of antihypertensive medications (SPYRAL HTN-OFF MED Pivotal): a multicentre, randomised, sham-controlled trial. The Lancet. 2020;395:1444-1451.